370 related articles for article (PubMed ID: 29410671)
1. Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults.
van der Heiden M; de Rond LGH; van Zelm MC; Berbers GAM; Boots AMH; Buisman AM
Front Immunol; 2018; 9():46. PubMed ID: 29410671
[TBL] [Abstract][Full Text] [Related]
2. Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.
Weinberg A; Canniff J; Rouphael N; Mehta A; Mulligan M; Whitaker JA; Levin MJ
J Immunol; 2017 Jul; 199(2):604-612. PubMed ID: 28607114
[TBL] [Abstract][Full Text] [Related]
3. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
[TBL] [Abstract][Full Text] [Related]
5. Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge.
Patel NP; Vukmanovic-Stejic M; Suarez-Farinas M; Chambers ES; Sandhu D; Fuentes-Duculan J; Mabbott NA; Rustin MHA; Krueger J; Akbar AN
J Infect Dis; 2018 Sep; 218(suppl_2):S88-S98. PubMed ID: 30247603
[TBL] [Abstract][Full Text] [Related]
6. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.
Laing KJ; Russell RM; Dong L; Schmid DS; Stern M; Magaret A; Haas JG; Johnston C; Wald A; Koelle DM
J Infect Dis; 2015 Oct; 212(7):1022-31. PubMed ID: 25784732
[TBL] [Abstract][Full Text] [Related]
7. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
8. Identification and Characterization of CD4
Voic H; de Vries RD; Sidney J; Rubiro P; Moore E; Phillips E; Mallal S; Schwan B; Weiskopf D; Sette A; Grifoni A
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999027
[TBL] [Abstract][Full Text] [Related]
9. Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4
Haredy AM; Takei M; Iwamoto SI; Ohno M; Kosaka M; Hirota K; Koketsu R; Okuno T; Ikuta K; Yamanishi K; Ebina H
Vaccine; 2019 Aug; 37(36):5225-5232. PubMed ID: 31358406
[TBL] [Abstract][Full Text] [Related]
10. Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.
Perciani CT; Jaoko W; Walmsley S; Farah B; Mahmud SM; Ostrowski M; Anzala O; Team KI; MacDonald KS
BMJ Open; 2017 Sep; 7(9):e017391. PubMed ID: 28939581
[TBL] [Abstract][Full Text] [Related]
11. Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women.
Perciani CT; Sekhon M; Hundal S; Farah B; Ostrowski MA; Anzala AO; McKinnon LR; Jaoko W; MacDonald KS;
J Infect Dis; 2018 Sep; 218(8):1210-1218. PubMed ID: 29800309
[TBL] [Abstract][Full Text] [Related]
12. Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults.
Schwarz TF; Volpe S; Catteau G; Chlibek R; David MP; Richardus JH; Lal H; Oostvogels L; Pauksens K; Ravault S; Rombo L; Sonder G; Smetana J; Heineman T; Bastidas A
Hum Vaccin Immunother; 2018 Jun; 14(6):1370-1377. PubMed ID: 29461919
[TBL] [Abstract][Full Text] [Related]
13. Serological and T Cell Responses After Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis.
Righi E; Carnelutti A; La Rosa A; Sartor A; Tulissi P; Gallo T; Ivaldi F; Bassetti M
Viral Immunol; 2019 Apr; 32(3):151-157. PubMed ID: 30694731
[TBL] [Abstract][Full Text] [Related]
14. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation.
Perciani CT; Farah B; Kaul R; Ostrowski MA; Mahmud SM; Anzala O; Jaoko W; ; MacDonald KS
J Clin Invest; 2019 Feb; 129(2):875-886. PubMed ID: 30511963
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C
Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381
[TBL] [Abstract][Full Text] [Related]
16. Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults.
Chlibek R; Pauksens K; Rombo L; van Rijckevorsel G; Richardus JH; Plassmann G; Schwarz TF; Catteau G; Lal H; Heineman TC
Vaccine; 2016 Feb; 34(6):863-8. PubMed ID: 26432913
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C
J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990
[TBL] [Abstract][Full Text] [Related]
18. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
19. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.
Levin MJ; Oxman MN; Zhang JH; Johnson GR; Stanley H; Hayward AR; Caulfield MJ; Irwin MR; Smith JG; Clair J; Chan IS; Williams H; Harbecke R; Marchese R; Straus SE; Gershon A; Weinberg A;
J Infect Dis; 2008 Mar; 197(6):825-35. PubMed ID: 18419349
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
